MyFinsight
Home
Blog
About
Cash and cash
equivalents
$166,502K
(99.70%↑ Y/Y)
Marketable securities,
available for sale
$9,884K
Prepaid expenses and
other current assets
$1,291K
(9.59%↑ Y/Y)
Property and equipment,
gross
$2,082K
(-4.28%↓ Y/Y)
Total current assets
$177,677K
(110.14%↑ Y/Y)
Operating lease
right-of-use asset
$840K
(44.58%↑ Y/Y)
Property and equipment,
net
$435K
(-47.02%↓ Y/Y)
Other assets
$401K
(245.69%↑ Y/Y)
Less accumulated
depreciation and...
$1,647K
(21.64%↑ Y/Y)
Total assets
$179,353K
(108.38%↑ Y/Y)
Total liabilities and
stockholders' equity
$179,353K
(108.38%↑ Y/Y)
Total stockholders'
equity
$172,108K
(120.18%↑ Y/Y)
Total liabilities
$7,245K
(-8.34%↓ Y/Y)
Accumulated deficit
-$244,744K
(-31.56%↓ Y/Y)
Accumulated other
comprehensive loss
-$13K
Additional paid-in capital
$416,861K
(57.78%↑ Y/Y)
Total current
liabilities
$6,643K
(-12.56%↓ Y/Y)
Long-term operating lease
liabilities
$590K
(120.97%↑ Y/Y)
Other long-term
liabilities
$12K
(-70.00%↓ Y/Y)
Common stocks-Common
Class A
$4K
(300.00%↑ Y/Y)
Accrued expenses and
other current...
$4,308K
Accounts payable
$1,999K
(-16.04%↓ Y/Y)
Operating lease
liabilities, current portion
$336K
(-39.57%↓ Y/Y)
Back
Back
Balance Sheet
OnKure Therapeutics, Inc. (OKUR)
OnKure Therapeutics, Inc. (OKUR)
source: myfinsight.com